Ali Yetisen

Ali K. Yetisen (born 1986) is a Turkish biomedical engineer and scientist of Department of Chemical Engineering and Biotechnology, University of Cambridge. He is best known for his work in the areas of in vitro diagnostics, holographic sensor, microfluidics, and Bragg mirror.
Education and academic career
He received his B.S. degree from University of Arizona in 2010 and earned a Ph.D. in Biotechnology from the University of Cambridge in 2014. Under the tutelage of Christopher Robin Lowe. Yetisen' graduate work focused on the use of holography in lab-on-a-chip devices. Among other research endeavors, he studied diagnostics in public health and developing world economies.
Research at The University of Arizona
Yetisen began his career as a research assistant at the University of Arizona in 2008 and remained there until 2011. While at University of Arizona, he played a pivotal role in the development of the cancer diagnostic device, BenchMark ULTRA, which was commercialised by Hoffmann-La Roche.
Research at University of Cambridge
In 2011, Yetisen moved to the Department of Chemical Engineering and Biotechnology at University of Cambridge to work on point-of-care diagnostic devices.
Current research
Yetisen is currently Cambridge Infectious Diseases fellow at University of Cambridge, one of only 4 fellowships at the institution. He maintains an active research collaboration of over 20 graduate students and postdocs. His current research interests include "diagnostics for the developing world, global health, biosensors, microfluidics, telemedicine, micro- and nanotechnology, science for developing economies."
Awards and achievements
Yetisen is the author of more than 10 scientific articles and is listed as an inventor in a number of patents.
Among other awards, Yetisen is the recipient of the Cambridge Infectious Diseases Fellowship of the School of Clinical Medicine, University of Cambridge.
Yetisen is a member of the Royal Society of Chemistry, Cambridge Philosophical Society, Tau Beta Pi, and Phi Kappa Phi.
< Prev   Next >